Israpafant
Product Specifications
CAS Number
117279-73-9
Target
PAFR, Others
Related Pathways
GPCR/G Protein, Others
Bioactivity
Israpafant is a selective antagonist for the platelet-activating factor receptor (IC50 = 0.84nM) . Israpafant inhibits PAF-induced human platelet aggregation. Israpafant inhibits the activation of eosinophil cells and consequently delays the development of immune responses. Israpafant also has anti-nephrotoxic properties and to mobilize calcium transport.
Smiles
CC=1N2C3=C(C(=NC(C)C2=NN1)C4=C(Cl)C=CC=C4)C=C(CCC5=CC=C(CC(C)C)C=C5)S3
Molecular Formula
C28H29ClN4S
Molecular Weight
489.07
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-0862R-PE-Cy5 100 µL
Insulin Polyclonal Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details 
GTR15120787 1 Vial
Lentiviral human SLC10A1 shRNA (UAS) - Lentiviral human SLC10A1 shRNA (UAS) plasmid
Sign In for Pricing
View Details 
sc-339367 250 mg
2- ({2-[ (4-bromophenyl) amino]-2-oxoethyl}thio) propanoic acid
Sign In for Pricing
View Details 